Else Marit Inderberg

Dr Else Marit Inderberg obtained her BSc (Honours) from University of Reading, UK in 1998 and subsequently a Diplôme EPHE in Immunology in 2005 ( Ecole Pratique des Hautes Etudes, Sorbonne, Paris, France) and a PhD in tumour immunology in 2011 (University of Oslo, Norway). Dr Inderberg is currently a researcher and Head of Immunomonitoring at Oslo University Hospital-Radiumhospitalet, She has broad oncology-related clinical trial experience, particularly in therapeutic cancer vaccine trials. Dr Inderberg has participated in international harmonisation panels for immunomonitoring and in clinical protocol writing for vaccine trials as well as T-cell based therapy development. She has published original articles in several peer review scientific journals and is also a reviewer for several journals.